Рынок кастомизированных антител в США вырастет до 1,45 млрд долларов к 2033 году

Custom Antibody Services Market (2033): Monoclonal Antibodies, Antibody Development & AI-Powered Discovery Growth in United States Expansion | OriGene Technologies 09-07-2026 03:35 PM CET | Health & Medicine Press release from: DataM Intelligence 4Market Research LLP The Global Custom Antibody Services Market is estimated at US$679.0 million in 2025 and is projected to reach US$1,451.0 million by 2033, growing at a CAGR of 9.9% during 2026-2033. Growth is driven by rising demand for precision medicine, expanding biopharmaceutical R&D, increasing adoption of antibody-based therapeutics, growing biologics investments, and the use of customized antibodies in diagnostics, drug discovery, and therapeutic research. Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/custom-antibody-services-market?sindhuri Market expansion is supported by increasing demand for antibody development, production, labelling, and specialized services. Growing use of monoclonal, polyclonal, and recombinant antibodies, along with advancements in antibody engineering and AI-assisted antibody discovery, is improving specificity and development efficiency. The rapid growth of biopharmaceutical R&D and expanding drug pipelines are also encouraging pharmaceutical and biotechnology companies to outsource antibody development and production to specialized providers. Demand for targeted therapies, personalized medicine, antibody-drug conjugates, and advanced diagnostics is further supporting market growth. North America remains the dominant region due to strong biopharmaceutical R&D and advanced research infrastructure. Europe is witnessing steady growth, while Asia-Pacific is expected to be the fastest-growing region, supported by increasing life sciences funding, expanding pharmaceutical industries, and biotechnology investments in China, India, and Japan. Custom Antibody Services Market: Competitive Intelligence Major players include R&D Systems, Thermo Fisher Scientific, GenScript, Bio-Rad Laboratories, Sino Biological, Boster Biological Technology, RayBiotech Life, Bio-Techne, Elabscience Biotechnology, and Biocompare. Competition is shaped by antibody specificity, development speed, scalability, engineering capabilities, quality, customization, and technological expertise. Key strategies include expanding recombinant and monoclonal antibody solutions, integrating AI-assisted discovery, increasing production capabilities, and developing specialized solutions for oncology, immunology, infectious diseases, diagnostics, and therapeutic research. Upcoming Key Players Upcoming and emerging players expected to strengthen their presence in the Custom Antibody Services Market include OriGene Technologies, QED Biosciences, Bethyl Laboratories, Miltenyi Biotec, and Biomatik. These companies are expanding their capabilities in custom monoclonal and polyclonal antibody development, recombinant antibody engineering, high-throughput screening, custom conjugation, and application-specific validation. OriGene, for instance, provides integrated antibody development through large-scale GMP manufacturing, while Bio-Rad continues to advance recombinant antibody generation through phage-display technologies. Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/custom-antibody-services-market?sindhuri Recent Key Developments - United States & North America ✅ August 2026: Bristol Myers Squibb partnered with Chai Discovery to accelerate therapeutic antibody discovery using AI-powered molecular folding and design models, highlighting the growing integration of artificial intelligence into antibody engineering and candidate identification across North America. ✅ July 2026: Mosaic Biosciences and Tango Biosciences announced a strategic partnership to expand custom critical-reagent discovery, including anti-idiotype antibodies, ADA positive controls, and research antibodies, with validated reagents targeted for delivery in as little as four weeks. ✅ June 2026: Johnson & Johnson entered into an agreement to acquire Firefly Bio for US$1 billion, adding its degrader antibody-conjugate platform and strengthening next-generation antibody engineering capabilities for oncology applications in the United States. Recent Key Developments - Japan & Asia-Pacific ✅ August 2026: Ono Pharmaceutical and Mediar Therapeutics entered a drug discovery partnership to create novel antibody therapeutics for fibro-inflammatory diseases, leveraging Mediar's antibody discovery expertise and fibrosis-focused biology. ✅ July 2026: Samsung Bioepis and Proteina entered an agreement under a South Korean government-supported R&D initiative to identify novel antibody drug candidates using artificial intelligence, supporting the expansion of AI-enabled antibody discovery capabilities in Asia-Pacific. ✅ June 2026: Cyagen Biosciences and Macau University of Science and Technology launched a five-year strategic partnership combining AI-computational tools, fully human mouse models, antibody engineering, and translational research to accelerate next-generation fully human antibody discovery. Recent Key Developments - Product & Technology Innovation ✅ August 2026: AI-Driven Antibody Discovery: Partnerships involving Chai Discovery, Bristol Myers Squibb, Samsung Bioepis, and other industry players are accelerating the use of AI models for antibody design, molecular interaction prediction, candidate identification, and optimization. ✅ July 2026: Advanced Bispecific Antibody Platforms: Biocytogen and Whitehawk Therapeutics launched a global collaboration using Biocytogen's RenLite platform to discover, screen, and optimize fully human bispecific antibodies for next-generation antibody-drug conjugate development. ✅ August 2026: Next-Generation Antibody Conjugates: Research advances in antibody-oligonucleotide conjugates (AOCs), including positive early proof-of-concept results from VERAXA Biotech and Secarna Pharmaceuticals, are expanding antibody engineering beyond conventional therapeutics toward targeted delivery of oligonucleotide payloads. M&A / Strategic Activity Recent strategic acquisitions, partnerships, and ecosystem developments shaping the Custom Antibody Services Market: Adimab - Expansion of antibody discovery partnerships Adimab continued expanding its antibody discovery ecosystem through collaborations with biotechnology and pharmaceutical companies. In 2025, the company entered into 23 partnership agreements and expanded collaborations with multiple existing partners, supporting fully human monoclonal and multispecific antibody discovery programs. Y-Biologics & Pierre Fabre - Strategic immune-oncology collaboration Y-Biologics and Pierre Fabre established a strategic research collaboration and optional license agreement to explore immune-oncology targets using Y-monoclonal antibody technologies, demonstrating the growing role of customized antibody discovery in targeted therapeutics. Novartis - Acquisition-driven antibody conjugate capabilities Novartis strengthened its antibody-based therapeutic ecosystem through the acquisition of Avidity Biosciences, adding antibody-oligonucleotide conjugate capabilities and late-stage programs to its pipeline. The transaction highlights increasing strategic interest in antibody engineering and conjugation technologies. Novartis & Myricx Bio - Next-generation ADC ecosystem expansion In July 2026, Novartis agreed to acquire Myricx Bio to add a novel antibody-drug conjugate payload platform based on N-myristoyltransferase inhibitors, reinforcing the industry's move toward differentiated antibody engineering and targeted delivery technologies. CRDMO and antibody-service ecosystem integration Pharmaceutical and biotechnology companies are increasingly pursuing partnerships and integrated service models that combine antibody discovery, engineering, bioconjugation, development, and manufacturing capabilities, creating opportunities for custom antibody service providers to participate across the broader biologics development value chain. New Product/Service Launches & Deployments Recent innovations and deployments in the custom antibody services space: Antibody Solutions - Single plasma B-cell discovery services Antibody Solutions expanded its Cellestive discovery platform with single plasma B-cell services, enabling antibody screening against soluble antigens and target cells while recovering paired heavy- and light-chain sequences for novel antibody discovery. Proteintech - 3D epitope mapping capabilities Proteintech introduced enhanced antibody characterization using 3D Epitope Mapping, combining peptide scanning, microbial display, and AI modeling to provide more detailed visualization of antibody binding sites and support improved antibody selection. Bio-Rad Laboratories - HuCAL PLATINUM antibody library Bio-Rad continues to leverage its HuCAL PLATINUM phage-display library, containing more than 45 billion functional human antibody genes, to support human antibody discovery, expression, and further engineering. Adimab - Fully human and multispecific antibody discovery platforms Adimab continues deploying antibody discovery and engineering capabilities for fully human monoclonal and multispecific antibodies across pharmaceutical and biotechnology collaborations, supporting an expanding pipeline of therapeutic antibody programs. AI-enabled antibody discovery and characterization Service providers and technology developers are increasingly integrating AI-assisted antibody discovery, epitope prediction, sequence analysis, and molecular characterization into custom antibody workflows to improve specificity and shorten development cycles. R&D & Technological Advancements AI-powered antibody discovery and engineering Research is increasingly focused on applying artificial intelligence and machine learning to antibody sequence optimization, epitope prediction, affinity maturation, and candidate selection, helping reduce development timelines and improve antibody specificity. Recombinant and monoclonal antibody engineering Advanced recombinant and monoclonal antibody technologies are being developed to improve reproducibility, affinity, specificity, stability, and scalability for research, diagnostic, and therapeutic applications. Multispecific antibody development R&D is accelerating around bispecific and multispecific antibodies capable of simultaneously targeting multiple antigens or biological pathways, expanding opportunities for customized antibody engineering services. Advanced epitope mapping and characterization High-resolution epitope mapping technologies are being developed to characterize antibody-antigen interactions more precisely, supporting better candidate selection and therapeutic antibody optimization. Antibody-drug conjugate and conjugation technologies Growing investment in ADCs is driving innovation in antibody engineering, linker technologies, payload attachment, and site-specific conjugation, increasing demand for specialized antibody development and characterization services. Animal-free and alternative antibody generation Research is increasingly exploring recombinant, synthetic, phage-display, yeast-display, and other animal-reduced antibody generation approaches to improve scalability, reproducibility, and ethical sustainability. Unlock & Gain Complete 360° Market Visibility: https://www.datamintelligence.com/buy-now-page?report=custom-antibody-services-market?sindhuri Segments Covered in the Global Custom Antibody Services Market: By Service The market is segmented into antibody development (40%), antibody production (30%), antibody labelling (18%), and others (12%). Antibody development dominates the market due to increasing demand for customized monoclonal, polyclonal, and recombinant antibodies for drug discovery, biomarker research, and diagnostic applications. Antibody production is witnessing strong growth driven by rising biopharmaceutical research and the need for scalable, high-quality antibody manufacturing. Antibody labelling is increasingly used in immunoassays, imaging, and research workflows, while other services support specialized customization and downstream applications. By Type The market is divided into monoclonal antibodies (42%), polyclonal antibodies (30%), recombinant antibodies (20%), and others (8%). Monoclonal antibodies dominate the market due to their high specificity, reproducibility, and extensive use in pharmaceutical research, diagnostics, and therapeutic development. Recombinant antibodies are witnessing strong growth driven by advances in antibody engineering and increasing demand for highly consistent and scalable research reagents. Polyclonal antibodies remain widely used in research and diagnostic applications, while other antibody types serve specialized applications. By Source The market is segmented into rabbits (35%), chickens (20%), mice (30%), guinea pigs (10%), and others (5%). Rabbits account for a leading share due to their ability to generate high-affinity antibodies and their increasing use in research and diagnostic applications. Mice remain widely used for monoclonal antibody development because of established hybridoma technologies and extensive research applications. Chicken-derived antibodies are witnessing increasing adoption due to their ability to target conserved mammalian proteins, while guinea pigs and other sources serve specialized research requirements. By End-User The market is divided into pharmaceutical companies (45%), contract research organizations (35%), and others (20%). Pharmaceutical companies dominate the market due to increasing investment in drug discovery, biologics development, biomarker identification, and precision medicine. Contract research organizations are witnessing strong growth as pharmaceutical and biotechnology companies increasingly outsource antibody development, production, characterization, and validation activities to reduce development timelines and costs. Other end-users, including academic institutions, diagnostic companies, and research laboratories, contribute to steady demand. By Region North America - 38% Share North America leads the market due to the presence of major pharmaceutical and biotechnology companies, strong investment in drug discovery and life sciences research, and increasing adoption of customized antibody solutions across therapeutic, diagnostic, and academic applications in the United States and Canada. Europe - 27% Share Europe is driven by expanding biopharmaceutical research, growing demand for precision medicine, strong academic and clinical research infrastructure, and increasing investments in antibody-based therapeutics and diagnostics, particularly across Germany, the UK, France, and Switzerland. Asia-Pacific - 23% Share Asia-Pacific is expanding rapidly due to increasing pharmaceutical and biotechnology R&D activities, rising investments in life sciences infrastructure, growing outsourcing of research services, and expanding demand for customized antibodies in countries such as China, Japan, South Korea, and India. Contact Us - Company Name: DataM Intelligence Contact Person: Sai Kiran Email: [email protected] Phone: +1 877 441 4866 Website: https://www.datamintelligence.com About Us - DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele. This release was published on openPR. Permanent link to this press release: Copy Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release. You can edit or delete your press release Custom Antibody Services Market (2033): Monoclonal Antibodies, Antibody Development & AI-Powered Discovery Growth in United States Expansion | OriGene Technologies here News-ID: 4623911 • Views: … Japan Building Automation Market: Automation ROI, Labor Substitution and Integra … Global Building Automation Market is entering a high value transformation phase as building owners, facility managers, real estate developers and industrial operators increasingly prioritize energy efficiency, operational automation, security, indoor environmental quality and measurable returns on technology investments. The global building automation market was valued at US$ 117.2 billion in 2025 and is expected to reach US$ 255.5 billion in 2033, growing at a CAGR of 10.2% during the forecast … 09-07-2026 | Food & Beverage DataM Intelligence 4Market Research LLP Package Testing Market (2033): Physical Testing, Food & Beverage Packaging & E-c … The Global Package Testing Market is estimated at US$15.47 billion in 2025 and is projected to reach US$35.21 billion by 2033, growing at a CAGR of 10.82% during 2026-2033. Growth is driven by stringent packaging regulations, rising demand for safe and durable packaging, increasing packaged food consumption, e-commerce expansion, and the need to prevent product damage and contamination across supply chains. Download your exclusive sample report today (corporate email gets priority … 09-07-2026 | Aerospace & Defense DataM Intelligence 4market Research LLP Defense Cybersecurity Market (2035): AI & Machine Learning, Zero Trust Security … The Global Defense Cybersecurity Market is estimated at US$40.06 billion in 2025 and is projected to reach US$83.32 billion by 2035, growing at a CAGR of 7.6% during 2026-2035. Growth is driven by rising cyber warfare threats, defense digitalization, geopolitical tensions, increasing cybersecurity investments, and the need to protect mission-critical military networks, communications, intelligence systems, and connected platforms. Download your exclusive sample report today (Corporate email gets priority access): https://www.datamintelligence.com/download-sample/defense-cybersecurity-market?sindhuri Market growth is … What Japan Buyers Require Before Scaling Digital Transformation Across Banking F … The global digital transformation market is entering a new phase in which enterprise buyers are shifting attention from technology adoption alone toward secure integration, measurable returns, data governance and long-term scalability. The Global Digital Transformation Market reached US$ 1,119.30 billion in 2025 and is expected to reach US$ 5,641.90 billion by 2033, growing at a CAGR of 23.0% during the forecast period 2026-2033. For Japanese enterprises, particularly organizations operating across Banking, … All 5 Releases 11-21-2023 | Health & Medicine ReportsnReports Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols … The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with … Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado … The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth … 06-08-2023 | Industry, Real Estate & Constr … ReportsnReports Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report … Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz … Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary … 02-28-2019 | Business, Economy, Finances, B … Qurate Business Intelligence IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included … A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the … Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | … A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the …